Medication and procedural abortions before 13 weeks gestation and risk of psychiatric disorders

被引:0
|
作者
Steinberg, Julia R. [1 ]
Laursen, Thomas M. [2 ,3 ]
Lidegaard, Ojvind [4 ]
Munk-Olsen, Trine [3 ,5 ]
机构
[1] Univ Maryland, Dept Family Sci, College Pk, MD 20742 USA
[2] Aarhus Univ, CIRRAU Ctr Integrated Register Based Res, Aarhus, Denmark
[3] Aarhus Univ, NCRR Natl Ctr Register Based Res, Aarhus, Denmark
[4] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[5] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
关键词
medication and procedural abortion; mental health; MENTAL-HEALTH; SURGICAL TERMINATION; VACUUM ASPIRATION; EMOTIONAL IMPACT; MIFEPRISTONE; PREGNANCY; WOMEN;
D O I
10.1016/j.ajog.2024.05.025
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The proportion of abortions provided by medication in the United States and worldwide has increased greatly since the U.S. Food and Drug Administration approved mifepristone in 2000. While existing research has shown that abortion does not increase risk of mental health problems, no population-based study has examined specifically whether a procedural or medication abortion increases risk of mental health disorders. Objective: This study examined whether mental health disorders increased in the shorter and longer-term after a medication or procedural abortion. Study design: Using Danish population registers' data, we conducted a prospective cohort study in which we included 72,424 females born in Denmark between 1980 and 2006, who were ages 12 to 38 during the study period and had a first first-trimester abortion before 13 weeks gestation in 2000 to 2018. Females with no previous psychiatric diagnoses were followed from 1 year before their abortion until their first psychiatric diagnosis, December 31, 2018, emigration from Demark, or death, whichever came first. Risk of any first psychiatric disorder was defined as a recorded psychiatric diagnosis at an in- or out-patient facility from the 1 year after to more than 5 years after a medication or procedural abortion relative to the year beforehand. Results were adjusted for calendar year, age, gestational age, partner status, prior mental and physical health, childbirth history, childhood environment, and parental mental health history. Results: Females having medication (n=37,155) and procedural abortions (n=35,269) had the same risk of any first psychiatric diagnosis in the year after their abortion relative to the year before their abortion (medication abortion adjusted incidence rate ratio [MaIRR]=1.02, 95% confidence interval [CI]: 0.93-1.12; procedural abortion adjusted incidence rate ratio [PaIRR]=0.94, 95% CI: 0.86-1.02). Moreover, as more time from the abortion passed, the risk of a psychiatric diagnoses decreased relative to the year before their abortion for each abortion method (MaIRR 1-2 years after=0.89, 95% CI: 0.80-0.98; PaIRR 1-2 years after=0.81, 95% CI: 0.88-1.05; MaIRR 2-5 years after=0.77, 95% CI: 0.71-0.84; PaIRR 2-5 years after=0.72, 95% CI: 0.67-0.78; MaIRR 5+ years after=0.58, 95% CI: 0.53-0.63; PaIRR 5+ years after=0.54, 95% CI: 0.50-0.58). Conclusion: Because the risk of psychiatric diagnoses was the same in the year after relative to the year before a medication and procedural abortion and the risk did not increase as more time after the abortion increased, neither abortion method increased risk of mental health disorders in the shorter or longer-term.
引用
收藏
页码:437e1 / 437e18
页数:18
相关论文
共 50 条
  • [1] TRAIL Is Decreased Before 20 Weeks Gestation in Women with Hypertensive Disorders of Pregnancy
    Zhou, Cheng
    Long, Yan
    Yang, Hongling
    Zhu, Chunyan
    Ma, Qingling
    Zhang, Yonggang
    PLOS ONE, 2015, 10 (06):
  • [2] Coffee consumption and risk of hospitalized miscarriage before 12 weeks of gestation
    Parazzini, F
    Chatenoud, L
    Di Cintio, E
    Mezzopane, R
    Surace, M
    Zanconato, G
    Fedele, L
    Benzi, G
    HUMAN REPRODUCTION, 1998, 13 (08) : 2286 - 2291
  • [3] Risk factors for strabismus in children born before 32 weeks' gestation
    Pennefather, PM
    Clarke, MP
    Strong, NP
    Cottrell, DG
    Dutton, J
    Tin, W
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1999, 83 (05) : 514 - 518
  • [4] Risk of recurrence of PPROM after PPROM before 27 weeks gestation
    mol, Ben Willem
    van der Post, Joris
    Janssen, Tim
    Pajkrt, Eva
    Willekes, Christine
    Notten, Kim
    Porath, Martina
    van der Heyden, Jantien
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S195 - S195
  • [5] Chorionic Villus Sampling at 11 to 13 Weeks of Gestation and Hypertensive Disorders in Pregnancy
    Khalil, Asma
    Akolekar, Ranjit
    Pandya, Pranav
    Syngelaki, Argyro
    Nicolaides, Kypros
    OBSTETRICS AND GYNECOLOGY, 2010, 116 (02): : 374 - 380
  • [6] Maternal Hemodynamics at 11-13 Weeks of Gestation and the Risk of Preeclampsia
    Khalil, Asma
    Akolekar, Ranjit
    Syngelaki, Argyro
    ElKhaouli, Mohamed
    Nicolaides, Kypros
    REPRODUCTIVE SCIENCES, 2012, 19 (S3) : 323A - 323A
  • [7] Prediction of risk for vasa previa at 9-13 weeks' gestation
    Hasegawa, Junichi
    Nakamura, Masamitsu
    Sekizawa, Akihiko
    Matsuoka, Ryu
    Ichizuka, Kiyotake
    Okai, Takashi
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2011, 37 (10) : 1346 - 1351
  • [8] Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation
    Kagan, Karl O.
    Anderson, James M.
    Anwandter, Gabriel
    Neksasova, Katya
    Nicolaides, Kypros H.
    PRENATAL DIAGNOSIS, 2008, 28 (13) : 1209 - 1213
  • [9] Validation of a Spanish-language scale for evaluating perceived quality of care of medical abortions before 9 weeks gestation
    Rosa Cabedo-Ferreiro
    Maria-Mercedes Vicente-Hernández
    Josep-Maria Manresa-Domínguez
    Miriam Gómez-Masvidal
    Laura Montero-Pons
    Azahara Reyes-Lacalle
    Gemma Falguera-Puig
    BMC Women's Health, 22
  • [10] Validation of a Spanish-language scale for evaluating perceived quality of care of medical abortions before 9 weeks gestation
    Cabedo-Ferreiro, Rosa
    Vicente-Hernandez, Maria-Mercedes
    Manresa-Dominguez, Josep-Maria
    Gomez-Masvidal, Miriam
    Montero-Pons, Laura
    Reyes-Lacalle, Azahara
    Falguera-Puig, Gemma
    BMC WOMENS HEALTH, 2022, 22 (01)